Bayer AG
XETRA:BAYN

Watchlist Manager
Bayer AG Logo
Bayer AG
XETRA:BAYN
Watchlist
Price: 20.41 EUR -0.44%
Market Cap: 20.1B EUR
Have any thoughts about
Bayer AG?
Write Note

Bayer AG
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Bayer AG
Research & Development Peer Comparison

Comparables:
ATAI
MRK
93M1
DMP
PSG

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Bayer AG
XETRA:BAYN
Research & Development
-€5.5B
CAGR 3-Years
4%
CAGR 5-Years
0%
CAGR 10-Years
-5%
ATAI Life Sciences NV
NASDAQ:ATAI
Research & Development
-$62.2m
CAGR 3-Years
-76%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Merck KGaA
XETRA:MRK
Research & Development
-€2.5B
CAGR 3-Years
-2%
CAGR 5-Years
-2%
CAGR 10-Years
-5%
MPH Health Care AG
XETRA:93M1
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dermapharm Holding SE
XETRA:DMP
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
PharmaSGP Holding SE
XETRA:PSG
Research & Development
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Bayer AG's Research & Development?
Research & Development
-5.5B EUR

Based on the financial report for Jun 30, 2024, Bayer AG's Research & Development amounts to -5.5B EUR.

What is Bayer AG's Research & Development growth rate?
Research & Development CAGR 10Y
-5%

Over the last year, the Research & Development growth was 8%. The average annual Research & Development growth rates for Bayer AG have been 4% over the past three years , and -5% over the past ten years .

Back to Top